135 related articles for article (PubMed ID: 31708243)
21. Ultrasound vibro-elastography for assessing mechanical properties of porcine reproductive tissues in an ex vivo model.
Zhou B; Shao J; Kisby CK; Zhang X
Clin Biomech (Bristol, Avon); 2020 Aug; 78():105093. PubMed ID: 32619871
[TBL] [Abstract][Full Text] [Related]
22. IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis.
Chen T; Qiu H; Zhao MM; Chen SS; Wu Q; Zhou NY; Lu LQ; Song JC; Tang DL; Weng D; Li HP
J Cell Mol Med; 2019 Feb; 23(2):908-919. PubMed ID: 30378252
[TBL] [Abstract][Full Text] [Related]
23. Bleomycin Induces Drug Efflux in Lungs. A Pitfall for Pharmacological Studies of Pulmonary Fibrosis.
Park JK; Coffey NJ; Bodine SP; Zawatsky CN; Jay L; Gahl WA; Kunos G; Gochuico BR; Malicdan MCV; Cinar R
Am J Respir Cell Mol Biol; 2020 Feb; 62(2):178-190. PubMed ID: 31419911
[TBL] [Abstract][Full Text] [Related]
24. Structural and functional correlations in a large animal model of bleomycin-induced pulmonary fibrosis.
Organ L; Bacci B; Koumoundouros E; Barcham G; Milne M; Kimpton W; Samuel C; Snibson K
BMC Pulm Med; 2015 Jul; 15():81. PubMed ID: 26227819
[TBL] [Abstract][Full Text] [Related]
25. Indocyanine-enhanced mouse model of bleomycin-induced lung fibrosis with hallmarks of progressive emphysema.
Grandi A; Ferrini E; Mecozzi L; Ciccimarra R; Zoboli M; Leo L; Khalajzeyqami Z; Kleinjan A; Löwik CWGM; Donofrio G; Villetti G; Stellari FF
Am J Physiol Lung Cell Mol Physiol; 2023 Feb; 324(2):L211-L227. PubMed ID: 36625471
[TBL] [Abstract][Full Text] [Related]
26. Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury.
Aono Y; Ledford JG; Mukherjee S; Ogawa H; Nishioka Y; Sone S; Beers MF; Noble PW; Wright JR
Am J Respir Crit Care Med; 2012 Mar; 185(5):525-36. PubMed ID: 22198976
[TBL] [Abstract][Full Text] [Related]
27. Exercise attenuates pulmonary injury in mice with bleomycin-induced pulmonary fibrosis.
Prata LO; Oliveira FM; Ribeiro TM; Almeida PW; Cardoso JA; Rodrigues-Machado Mda G; Caliari MV
Exp Biol Med (Maywood); 2012 Aug; 237(8):873-83. PubMed ID: 22903133
[TBL] [Abstract][Full Text] [Related]
28. FGF10 Therapeutic Administration Promotes Mobilization of Injury-Activated Alveolar Progenitors in a Mouse Fibrosis Model.
Lv YQ; Cai GF; Zeng PP; Dhlamini Q; Chen LF; Chen JJ; Lyu HD; Mossahebi-Mohammadi M; Ahmadvand N; Bellusci S; Li X; Chen C; Zhang JS
Cells; 2022 Aug; 11(15):. PubMed ID: 35954241
[TBL] [Abstract][Full Text] [Related]
29. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
Duan FF; Barron G; Meliton A; Mutlu GM; Dulin NO; Schuger L
Am J Respir Cell Mol Biol; 2019 Feb; 60(2):221-231. PubMed ID: 30230348
[TBL] [Abstract][Full Text] [Related]
30. Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model.
Shieh JM; Tseng HY; Jung F; Yang SH; Lin JC
Mediators Inflamm; 2019; 2019():7947596. PubMed ID: 31049028
[TBL] [Abstract][Full Text] [Related]
31. Aucuparin Suppresses Bleomycin-Induced Pulmonary Fibrosis Via Anti-Inflammatory Activity.
Lee SY; Park SY; Lee GE; Kim H; Kwon JH; Kim MJ; Yoon HG
J Med Food; 2021 Feb; 24(2):151-160. PubMed ID: 33512266
[TBL] [Abstract][Full Text] [Related]
32. Immune Mechanisms of Pulmonary Fibrosis with Bleomycin.
Ishida Y; Kuninaka Y; Mukaida N; Kondo T
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834561
[TBL] [Abstract][Full Text] [Related]
33. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis pathways of idiopathic pulmonary fibrosis in bleomycin-induced lung injury model in mice.
Shi K; Jiang J; Ma T; Xie J; Duan L; Chen R; Song P; Yu Z; Liu C; Zhu Q; Zheng J
Respir Physiol Neurobiol; 2014 Jan; 190():113-7. PubMed ID: 24140943
[TBL] [Abstract][Full Text] [Related]
35. Allies or enemies? The effect of regulatory T cells and related T lymphocytes on the profibrotic environment in bleomycin-injured lung mouse models.
Seyran M; Melanie S; Philip S; Amiq G; Fabian B
Clin Exp Med; 2023 Aug; 23(4):1075-1088. PubMed ID: 36403186
[TBL] [Abstract][Full Text] [Related]
36. Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice.
Cai Y; Kimura S
PLoS One; 2015; 10(11):e0142497. PubMed ID: 26559674
[TBL] [Abstract][Full Text] [Related]
37. MAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis.
Boehme SA; Franz-Bacon K; DiTirro DN; Ly TW; Bacon KB
PLoS One; 2016; 11(5):e0154874. PubMed ID: 27144281
[TBL] [Abstract][Full Text] [Related]
38. Multifocal acoustic radiation force-based reverberant optical coherence elastography for evaluation of ocular globe biomechanical properties.
Mekonnen T; Zevallos-Delgado C; Singh M; Aglyamov SR; Larin KV
J Biomed Opt; 2023 Sep; 28(9):095001. PubMed ID: 37701876
[TBL] [Abstract][Full Text] [Related]
39. Effect of a Thin Fluid Layer on Surface Wave Speed Measurements: A Lung Phantom Study.
Zhou J; Zhang X
J Ultrasound Med; 2019 May; 38(5):1361-1365. PubMed ID: 30208217
[TBL] [Abstract][Full Text] [Related]
40. Forefront: MiR-34a-Knockout Mice with Wild Type Hematopoietic Cells, Retain Persistent Fibrosis Following Lung Injury.
Bulvik R; Biton M; Berkman N; Breuer R; Wallach-Dayan SB
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
